Skip to main content
Magenta logo

Magenta

Security and trust center evidence

Magenta is the agent platform that automates complex manufacturing

Summary

Magenta has 1 registry-verified row and 1 vendor-stated row in the CertReports index, last verified 2 Nov 2026. The strongest row is SOC 2: Vendor states SOC 2 Type II on its trust centre. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 21 Sep 2026, Magenta states on its trust centre that it holds a SOC 2 Type II report. The SOC 2 statement, as of 21 Sep 2026, is a vendor-stated claim rather than a registry listing. As of 09 Oct 2026, Magenta is listed in the FedRAMP registry with a status of FedRAMP Ready. The FedRAMP Ready status, as of 09 Oct 2026, was assessed by Ignyte Platform Inc. For HIPAA, no public evidence found for Magenta as of 09 Oct 2026.

  • SOC 2: vendor states it holds a SOC 2 Type II report, as of 21 Sep 2026
  • FedRAMP: listed in FedRAMP registry as FedRAMP Ready, as of 09 Oct 2026, assessed by Ignyte Platform Inc.
  • HIPAA: no public evidence found as of 09 Oct 2026

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 10 Oct 2026; it is regenerated whenever a row changes.

Among manufacturing and industrial vendors

1verified rows

Category median 1, across 48 indexed manufacturing and industrial vendors. Magenta has more verified rows than 48 percent of them.

ai agentsinvoice matchingmanufacturing workflowssupplier data

Compliance grid

Subprocessors

No subprocessor list captured yet.

Change history

  1. 18 Sep 2026SOC 2 evidence addedA SOC 2 row entered the index with state Vendor-stated.

Similar vendors with evidence

Related by product tags and the Manufacturing and industrial category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.

Evidence against regulations

All regulations for Magenta

How much of each regulation’s vendor requirements Magenta’s public evidence reaches.

All articles